Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

64.7K
Overview
64.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Ratio of Immunogenicity: A quantitative metric to identify highly immunogenic protein antigens to improve tissue-engineered biomaterials.

Biomaterials·2026
Same author

Building Artificial Intelligence and Data Literacy Across the Health Care Research Workforce in the Mayo Clinic Center for Clinical and Translational Science: Why It Matters and What We Are Doing About It.

Mayo Clinic proceedings·2026
Same author

Identification of Antibody-Cognate Antigens via a High-Throughput, Affinity Chromatography-Based, Shotgun Immunoproteomics Pipeline.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Author Correction: Adhesive anti-fibrotic interfaces on diverse organs.

Nature·2025
Same author

A bioadhesive pacing lead for atraumatic cardiac monitoring and stimulation in rodent and porcine models.

Science translational medicine·2024
Same author

Outcome-based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A Systematic Review.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2024

Related Experiment Video

Updated: May 3, 2026

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies
08:10

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies

Published on: March 21, 2019

6.2K

Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization.

Maelene L Wong1, Leigh G Griffiths2

  • 1Department of Veterinary Medicine: Medicine and Epidemiology, University of California, Davis, One Shields Ave., Davis, CA 95616, USA; Department of Biomedical Engineering, University of California, Davis, One Shields Ave., Davis, CA 95616, USA.

Acta Biomaterialia
|February 4, 2014
PubMed
Summary

Xenogeneic scaffolds offer advantages for tissue engineering due to their extracellular matrix (ECM). However, reducing xenoantigens is crucial to prevent immune rejection for clinical applications.

Keywords:
Antigen removalDecellularizationExtracellular matrixTissue engineeringXenogeneic scaffold

More Related Videos

Fabrication of Decellularized Cartilage-derived Matrix Scaffolds
08:02

Fabrication of Decellularized Cartilage-derived Matrix Scaffolds

Published on: January 7, 2019

10.5K
Two Methods for Decellularization of Plant Tissues for Tissue Engineering Applications
05:20

Two Methods for Decellularization of Plant Tissues for Tissue Engineering Applications

Published on: May 31, 2018

14.6K

Related Experiment Videos

Last Updated: May 3, 2026

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies
08:10

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies

Published on: March 21, 2019

6.2K
Fabrication of Decellularized Cartilage-derived Matrix Scaffolds
08:02

Fabrication of Decellularized Cartilage-derived Matrix Scaffolds

Published on: January 7, 2019

10.5K
Two Methods for Decellularization of Plant Tissues for Tissue Engineering Applications
05:20

Two Methods for Decellularization of Plant Tissues for Tissue Engineering Applications

Published on: May 31, 2018

14.6K

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Immunology

Background:

  • Xenogeneic scaffolds, derived from animal tissues, are valuable in tissue engineering for their inherent extracellular matrix (ECM) composition and architecture.
  • The native ECM provides essential mechanical properties and biological cues for cell development, making it a promising biomaterial.
  • Xenogeneic tissues are readily available, offering a scalable source for scaffold generation.

Purpose of the Study:

  • To evaluate scaffold acellularity as a metric for assessing reduced immunogenicity in xenogeneic scaffolds.
  • To emphasize the necessity of antigen removal during xenogeneic scaffold processing for successful clinical translation.

Main Methods:

  • Review of existing literature on xenogeneic scaffold development and immunogenicity.
  • Analysis of acellularity as an indicator of immunological barrier reduction.
  • Discussion on antigen removal strategies in xenogeneic scaffold engineering.

Main Results:

  • Scaffold acellularity alone may not be a sufficient outcome measure for complete immunological barrier reduction.
  • Significant host immune rejection responses can occur if xenoantigens are not adequately addressed.
  • Effective antigen removal is critical for the in vivo survival of xenogeneic scaffold-derived tissues and organs.

Conclusions:

  • Tissue engineers must prioritize comprehensive antigen removal during xenogeneic scaffold generation.
  • Achieving sufficient reduction of xenoantigens is paramount for overcoming immune rejection and enabling clinical use of engineered tissues.
  • Further research is needed to establish robust methods for assessing and ensuring adequate antigen removal.